The mutation of such genes, including Atg16l1, immunity-related GTPase M (Irgm), nucleotide-binding oligomerization domain-containing protein 2 (Nod2) and so on, has been reported to contribute to the pathogenesis and progression of IBD. Here, IRGM is linked to inflammatory bowel disease.